OncoLens Virtual Tumor Board Security – Letter from CEO

August 17, 2020

Dear OncoLens Customer, Through the COVID-19 crisis, we are honored that we are able to continue to serve you and your patients. Over the past few weeks, most of you have transitioned to utilize our Virtual Tumor Board solution. With recent concerns hitting news channels around the security of virtual screen sharing solutions, you may […]

Read More +

What Cancer Centers Need to Know about the Changing CoC Accreditation Standards

November 19, 2019

Areas of biggest impact: Personnel/Services Resources and Patient Care Expectations   The Commission on Cancer recently released changes to its accreditation standards, a move that is expected to impact accredited facilities in the year 2020. It’s important that every cancer program administrator understands these changes, whether your facility is currently accredited or is considering pursuing […]

Read More +

OncoLens ESMO 2019 highlights- Breast Cancer

October 15, 2019

The European Society for Medical Oncology( ESMO) held its annual meeting in Barcelona Spain between 27th September and 1st October 2019. We highlight three potentially practice changing Breast Cancer trials presented at this conference. 1. BROCADE 3 trial This was a Phase 3 Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the PARP […]

Read More +